Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis
- 1 July 2013
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 11 (7), 841-846
- https://doi.org/10.1016/j.cgh.2012.12.032
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitisAlimentary Pharmacology & Therapeutics, 2011
- Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008BMC Gastroenterology, 2010
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseasesJournal of Hepatology, 2009
- Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic AcidGastroenterology, 2009
- Ursodeoxycholic acid for primary biliary cirrhosisPublished by Wiley ,2008
- High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effectiveJournal of Hepatology, 2008
- Transplantation Trends in Primary Biliary CirrhosisClinical Gastroenterology and Hepatology, 2007
- Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic AcidGastroenterology, 2006
- Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferationNutrition and Cancer, 1998
- Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.Gut, 1996